Tag Archives: implantable defibrillators

Introduction Most clinicians support the idea of person-centred care as a model of best practice, yet we know from published research and National Health Service (NHS) patient surveys that people still want to be more involved in decisions about their healthcare.1,2 In shared decision-making (SDM), healthcare professionals and individuals work together to select tests, treatments, management or support packages based on evidence and the individual’s informed preferences.3 This evidence should be the best available assessment of the likely benefits, risks, and outcomes of the options, with the individual’s values and preferences being cent

Pacing practice has moved on from the start with unipolar pacing and now practice includes implantable defibrillators and cardiac resynchronisation therapy (CRT) for the treatment of heart failure, with parallel developments in remote follow up. Direct His Bundle pacing is now feasible using specially designed guide catheters and a standard pacing lead and appears to have significant benefits with reductions in heart failure hospitalisation, atrial fibrillation and mortality. The supplement also looks at progress in pacemaker and defibrillator lead extraction, as well as the fast evolving field of leadless pacing. We are pleased to provide �

Details of two biomarker discovery programmes were presented by myself and other colleagues from Southampton.The early results were generated by our team, headed by Professor John Morgan, and build on several years of collaboration between cardiologists at the University Hospitals Southampton and scientists at the University of Southampton. The work hopes to advance sudden cardiac death risk stratification and ultimately move towards a more personal selection of interventions, such as implantable defibrillators. Traditional risk stratification markers, such as left ventricular function or QRS width, fail to identify those at greatest risk, or